quality&#039

February 9, 2017

Pot luck? Medical marijuana's 'questionable quality' no threat to pharma R&D

Standardization and quality were also of concern to George Anastassov, CEO of Axim Biotechnologies, a firm whose pharmaceutical grade CBD and ……

Read More